Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders

Clinical Neuropharmacology

Volumn 32, Issue 5, 2009, Pages 254-258

  Tarlaci, Sultan ^a  

^a Özel Ege Sa lNk Hastanesi   (Turkey)

Author keywords

Anxiety; Depression; Escitalopram; Migraine; Prophylactic treatment; Venlafaxine

Indexed keywords

ESCITALOPRAM; VENLAFAXINE;

ABSENTEEISM; ADULT; ARTICLE; CLINICAL TRIAL; DISABILITY; DISEASE SEVERITY; DIZZINESS; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; INSOMNIA; JOB PERFORMANCE; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; NERVOUSNESS; PAIN ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; PROSPECTIVE STUDY; SIDE EFFECT; SOMNOLENCE; WITHDRAWAL SYNDROME;

ADULT; CITALOPRAM; CYCLOHEXANOLS; FEMALE; HUMANS; MALE; MIGRAINE DISORDERS; MOOD DISORDERS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 70349976816     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181a8c84f     Document Type: Article

References (29)

1. VonKorff M, Resche LL, Dworkin SF. First onset of common pain symptoms: a prospective study of depression as a risk factor. Pain 1993;55:251-258.
2. Haythornthwaite JA. Migraine headaches and psychopathology: Future directions. J Psychiatr Res 1993;27:183-186.
3. Zwart JA, Dyb G, Hagen K, et al. Depression and anxiety disorders associated with headache frequency. The Nord-Trondelag Study. Eur J Neurol 2003;10:147-152.
4. Marazziti D, Toni C, Pedri S, et al. Prevalence of headache syndromes in panic disorder. Clin Psychopharmacol 1999;14:247-251.
5. Breslau N, Schultz LR, Stewart WF, et al. Headache types and panic disorder. Neurology 2001;56:350-354.
6. Marchesi C, De Ferri A, Petrolini N, et al. Prevalence of migraine and muscle tension headache in depressive disorders. J Affect Disord 1989;16:33-36.
7. Koch HJ, Jürgens TP. Antidepressants in long-term migraine prevention. Drugs 2009;69(1):1-19.
8. Ramadan NM. Current trends in migraine prophylaxis. Headache 2007;47(Suppl 1):S52-YS57.
9. Tasmuth T, Hartel B, Kalso E. Venlafaxine in neuropathic pain following treatment of breast cancer. Eur J Pain 2002;6(1):17-24.
10. Enggaard TP, Klitgaard NA, Gram LF, et al. Specific effect of venlafaxine on single and repetitive experimental painful stimuli in humans. Clin Pharmacol Ther 2001;69(4):245-251.
11. Sánchez C, BLgesL KP, Ebert B, et al. Escitalopram versus citalopram: the surprising role of the R-enantiomer. Psychopharmacology (Berl). 2004;174(2):163-176.
12. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004;24(Suppl 1):1-15.
13. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.
14. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatr 1961;4:561-571.
15. Stewart WF, Lipton RB. Work-related disability: results from the American Migraine Study. Cephalalgia 1996;16:231-238.
16. Hamelsky SW, Lipton RB. Psychiatric comorbidity of migraine. Headache 2006;46(9):1327-1333.
17. Houle T, Nash JM. Stress and headache chronification. Headache 2008;48:40-44.
18. Ward NG, Bloom VL, Friedel RO. The effectiveness of tricyclic antidepressants in the treatment of coexisting pain and depression. Pain 1979;7:331-341.
19. Snow V, Weiss K, Wall EM, et al. American Academy of Family Physicians; American College of Physicians-American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med 2002;137:840-849.
20. Torrente Castells E, Vázquez Delgado E, Gay Escoda C. Use of amitriptyline for the treatment of chronic tension-type headache. Review of the literature. Med Oral Patol Oral Cir Bucal 2008 1;13(9):E567YE572.
21. Lynch ME. Antidepressants as analgesics: a review of randomized controlled trials. J Psychiatry Neurosci 2001;26(1):30-36.
22. Ozyalcin SN, Talu GK, Kiziltan E, et al. The efficacy and safety of venlafaxine in the prophylaxis of migraine. Headache 2005; 45(2):144-152.
23. Adelman LC, Adelman JU, Von Seggern R, et al. Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: a retrospective study in a clinical setting. Headache 2000;40(7):572-580.
24. Zissis NP, Harmoussi S, Vlaikidis N, et al. A randomized, double-blind, placebo-controlled study of venlafaxine XR in out-patients with tension-type headache. Cephalalgia 2007;27(4):315-324.
25. Yucel A, Ozyalcin S, Talu KG, et al. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study. Eur J Pain 2005;9(4):407-416.
26. Karp JF. Venlafaxine XR and chronic pelvic pain syndrome. J Clin Psychiatry 2004;65(6):880-881.
27. Grothe DR, Scheckner B, Albano D. Treatment of pain syndromes with venlafaxine. Pharmacotherapy 2004;24(5):621-629.
28. Morton WA, Sonne SC, Verga MA. Venlafaxine: a structurally unique and novel antidepressant. Ann Pharmacother 1995;29(4):387-395.
29. Benedetti F, Mayberg HS, Wager TD, et al. Neurobiological mechanisms of the placebo effect. J Neurosci 2005;25(45): 10390-10402.